Performance of a Single-use Intermittent Micro-hole Zone Catheter
- Conditions
- Retention, UrinaryUrinary Incontinence
- Interventions
- Device: Comparator device -VaPro intermittent catheterDevice: Investigational device - intermittent catheter with a micro-hole zone
- Registration Number
- NCT05485922
- Lead Sponsor
- Coloplast A/S
- Brief Summary
The goal of this randomized, controlled crossover study was to assess the performance of a new micro-hole zone catheter compared to a conventional 2-eyelet catheter in 42 male intermittent catheter users.
The main objective of this study was to demonstrate superiority of the micro-hole zone catheter in terms of number of flow-stop episodes and residual volume at first flow-stop, with the catheterization performed by a health care professional in a hospital setting compared to a conventional two-eyelet catheter.
- Detailed Description
The investigation was a single-centre, randomized, controlled crossover study including 42 male participants comparing the performance of two intermittent catheters (IC).
The study included an information visit (visit 0) and two test visits (visit 1 and 2) in which one catheterization with either the investigational device or the comparator device, according to a randomization scheme, was performed by a health care professional in a hospital setting assessing flow stop episodes, bladder emptying and hematuria. There were 4-14 days between each test visit (visit 1 and 2) and visit 0 and 1 could be held on the same day.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 42
- Is Male
- Is at least 18 years of age and has full legal capacity
- Has given written informed consent
- Has signed letter of authority (only DK)
- Has used clean intermittent catheterisation CH12 or CH14 for at least one month
- Use intermittent catheterisation as the primary bladder emptying method
- Is able (assessed by investigator) and willing to follow study procedures
-
Is participating in any other clinical study during this investigation
-
Has previous participated in this study
-
Has symptoms of urinary tract infection as judged by the investigator 4 Is an individual with history, suspected or showing signs of producing urine with excessive amount of mucus or large/clustered sediments or debris
-
Has any known allergies towards ingredients in the investigational device
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Comparator device - VaPro intermittent catheter Comparator device -VaPro intermittent catheter Hollister VaPro, a single-use hydrophilic sleeved soft/flexible catheters in the sizes CH12 or CH14. The catheterization was performed by a trained nurse. Investigational device - intermittent catheter with a micro-hole zone Investigational device - intermittent catheter with a micro-hole zone A ready-to-use, sterile, hydrophilic-coated male catheter for intermittent catheterisation with a flexible tip and a micro-hole zone for urinary drainage in sizes CH12 and CH14. The catheterization was performed by a trained nurse.
- Primary Outcome Measures
Name Time Method Number of Flow-stop Episodes Immediately after catheterisation Flow-stop episodes were determined as instances where the flow rate decreased to less than 0.8 mL/s for a period of at least two seconds. All episodes were detected by automatic thresholding, followed by manual inspection, where the intra-catheter pressure readings were used to support the assessment of a flow stop.
Residual Urine at 1st Flow-stop When the first flow-stop appeared, the amount of voided urine was measured. The residual urine at 1st flow-stop during catheterization (performed by a nurse) represents the volume of urine left in the bladder, the first time the urine stops running out of the catheter during bladder emptying.
Hence, the residual volume at 1st flow-stop was calculated as the total volume post catheterisation minus the volume at 1st flow-stop, derived from a catheterisation profile which was connected to a time-logged weighing \[g\].
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Sanos Clinic
🇩🇰Gandrup, Denmark